about
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.Focused ultrasound in neurosurgery: a historical perspective.Intracranial Pressure Monitoring-Review and Avenues for Development.Volumetric analysis of magnetic resonance-guided focused ultrasound thalamotomy lesions.Letter: Big Data Research in Neurosurgery: A Critical Look at This Popular New Study Design.P18.12 Patient-reported outcome measures and health-related quality of life in patients who undergo an intervention for brain metastases: a systematic review.Information-Based Medicine in Glioma Patients: A Clinical Perspective.Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National CohortPredictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomasPredictors of survival in neurometastatic Merkel cell carcinomaThe Misclassification of Diffuse Gliomas: Rates and OutcomesTiming and Outcomes of Abdominal Surgery in Neutropenic PatientsUnilateral Thalamic Deep Brain Stimulation Versus Focused Ultrasound Thalamotomy for Essential TremorEfficacy and safety of immune checkpoint blockade for brain metastasesQuality of reporting and assessment of patient-reported health-related quality of life in patients with brain metastases: a systematic reviewCrossing the Cervicothoracic Junction in Posterior Cervical Decompression and Fusion: A Cohort AnalysisJean Talairach: a cerebral cartographerSurvival and prognostic factors in surgically treated brain metastasesOutcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysisEndocrine function and gland volume after endoscopic transsphenoidal surgery for nonfunctional pituitary macroadenomasHOUT-13. PATIENT REPORTED OUTCOME MEASURES IN BRAIN METASTASES PATIENTS – A SYSTEMATIC REVIEWLetter: Approaches to Mitigate Impact of COVID-19 Pandemic on Neurosurgical Residency Application Cycle
P50
Q35931778-CB27DF96-26BC-47B0-944D-B1AC6D805C05Q47701511-052DA8F6-3761-40C9-95C4-36D8320B0F5DQ48104407-B25756C3-8C56-4823-A229-2F5DDC707E9AQ49548872-34CCED24-8CD1-4A29-A30E-E529773C069FQ52606937-4AAD8195-50BE-4C0D-8CD8-7EC4EA4CA79BQ55340949-9C2381F7-84E5-4883-B89C-A0777F2C99AEQ55662441-282808DA-7D62-4FF5-B11D-095CE177313FQ90007528-3810232E-D75B-43E2-8C93-6A1985B4246AQ90184973-08DB41B8-370C-4606-BD61-EB0F5A2622A3Q90714871-CB06D287-F144-4FC8-8F98-C33D1D10E221Q91009746-A0DE0F5B-1801-47BB-BFC5-1B4D331845E0Q91118640-AD89D725-B705-47A5-ABB7-271C4C1DF475Q91834822-3BFD0FB1-A336-4181-B02D-31F6256CB83CQ92261316-942CB9D7-E557-4A9C-86AA-17E0997E278DQ92446290-6CDC1B33-1B7A-455A-84B4-4FAEE6FC7AF5Q92501081-CAF699BC-083B-402A-8812-C271C1A23D5FQ93038682-F584D58E-0E58-4CF8-AED3-770F6F497032Q93119449-55A5332B-062B-48C3-A05D-FF1BF2139830Q93345563-3A71619C-E0DE-466F-8D64-61D1B7F30607Q93371392-EE2C8900-3392-489E-AFDC-8D2F067A5F61Q94410010-29649B6D-06C2-4FE8-9F24-DCF97AE997E1Q94604364-16F10B7B-7EEA-42C4-B0E3-6DAB5E89C428
P50
description
researcher ORCID ID = 0000-0002-9962-8900
@en
wetenschapper
@nl
name
Maya Harary
@ast
Maya Harary
@en
Maya Harary
@es
Maya Harary
@nl
type
label
Maya Harary
@ast
Maya Harary
@en
Maya Harary
@es
Maya Harary
@nl
prefLabel
Maya Harary
@ast
Maya Harary
@en
Maya Harary
@es
Maya Harary
@nl
P31
P496
0000-0002-9962-8900